Anterix (ATEX) Is Up 6.0% After FCC Backs Satellite D2D Tests Over 900 MHz Spectrum

Anterix Inc.

Anterix Inc.

ATEX

0.00

  • In May 2026, Anterix and Lynk Global announced that the Federal Communications Commission approved an experimental license to test satellite direct-to-device communications over Anterix’s licensed 900 MHz broadband spectrum across multiple locations and devices.
  • This trial could help Anterix showcase how combining private 900 MHz networks with satellite connectivity might strengthen communications resilience for critical infrastructure operators such as utilities and transportation providers.
  • We’ll now examine how the FCC-backed satellite testing program may influence Anterix’s investment narrative around private utility broadband.

We've uncovered the 10 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Anterix Investment Narrative Recap

To own Anterix, you have to believe that utilities and other critical infrastructure will keep adopting private 900 MHz broadband as a foundational communications layer, and that Anterix can convert its spectrum holdings into durable cash flows rather than one off gains. The new FCC backed satellite trial with Lynk touches this story at the edges: it showcases a potential resilience enhancer, but the key near term catalyst remains utility contract wins, while regulatory and adoption timing still look like the biggest execution risks.

Among recent announcements, the FCC’s February 2026 Report and Order that enabled full 10 MHz broadband deployment is most tied to this Lynk news. That decision aligned the band with Anterix’s requested configuration, which in turn makes satellite direct to device testing at 900 MHz possible and could make Anterix’s licenses more useful to utilities considering richer, data intensive grid applications. Together, the R&O and this experiment frame how much value Anterix can ultimately attach to each new contract.

Yet beneath this promising narrative, investors should be aware that if utilities opt for alternative connectivity options over private 900 MHz networks, Anterix’s ability to monetize its spectrum at attractive levels could...

Anterix's narrative projects $6.9 million revenue and $935.0 thousand earnings by 2028. This requires 5.3% yearly revenue growth and a $94.7 million earnings decrease from $95.6 million today.

Uncover how Anterix's forecasts yield a $55.33 fair value, a 8% downside to its current price.

Exploring Other Perspectives

ATEX 1-Year Stock Price Chart
ATEX 1-Year Stock Price Chart

Some of the most optimistic analysts already expected revenue of about US$7.5 million and only US$1.0 million of earnings by 2028, yet they still saw upside if spectrum monetization and 10 MHz adoption accelerated faster than peers assume, showing how differently you and other investors might weigh this new FCC satellite trial against those expectations.

Explore 3 other fair value estimates on Anterix - why the stock might be worth 8% less than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Anterix research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
  • Our free Anterix research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Anterix's overall financial health at a glance.

Contemplating Other Strategies?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

  • Find 53 companies with promising cash flow potential yet trading below their fair value.
  • Rare earth metals are the new gold rush. Find out which 27 stocks are leading the charge.
  • Uncover the next big thing with 28 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.